WO2009010303A3 - System for administering active substances to an organism, devices for use in said type of system and method for producing said type of devices - Google Patents

System for administering active substances to an organism, devices for use in said type of system and method for producing said type of devices Download PDF

Info

Publication number
WO2009010303A3
WO2009010303A3 PCT/EP2008/005919 EP2008005919W WO2009010303A3 WO 2009010303 A3 WO2009010303 A3 WO 2009010303A3 EP 2008005919 W EP2008005919 W EP 2008005919W WO 2009010303 A3 WO2009010303 A3 WO 2009010303A3
Authority
WO
WIPO (PCT)
Prior art keywords
devices
active substances
type
organism
effect
Prior art date
Application number
PCT/EP2008/005919
Other languages
German (de)
French (fr)
Other versions
WO2009010303A2 (en
Inventor
Heribert Stephan
Werner Kraus
Stephanie Kraus
Original Assignee
Neue Magnetodyn Gmbh
Heribert Stephan
Werner Kraus
Stephanie Kraus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neue Magnetodyn Gmbh, Heribert Stephan, Werner Kraus, Stephanie Kraus filed Critical Neue Magnetodyn Gmbh
Publication of WO2009010303A2 publication Critical patent/WO2009010303A2/en
Publication of WO2009010303A3 publication Critical patent/WO2009010303A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/002—Magnetotherapy in combination with another treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a system for administering active substances to an organism, comprising at least one vibration generator (10), a coil arrangement (12, 14) that is electrically coupled to the vibration generator (10), at least one device (16, 42) that can be implanted in the region of a flowing body fluid and that consists at least partially of magnetically conductive material, and means (24, 26) for supplying paramagnetic nanoparticles with active substances that are coupled thereto in the flowing body fluids. The effect of the magnetic drug-targeting is improved, in which the highly magnetic gradient field is superimposed by a weak low-frequency electromagnetic field that synergistically improves the effect of the active substances or cells. Said synergistic effect can also be achieved by an alternating the use of the static highly magnetic field and the low-frequency electromagnetic field. The invention also relates to devices (16, 42) that can be implanted, to methods for the production thereof and systems and devices for carrying out telemetric measuring methods.
PCT/EP2008/005919 2007-07-18 2008-07-18 System for administering active substances to an organism, devices for use in said type of system and method for producing said type of devices WO2009010303A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007033452 2007-07-18
DE102007033452.6 2007-07-18

Publications (2)

Publication Number Publication Date
WO2009010303A2 WO2009010303A2 (en) 2009-01-22
WO2009010303A3 true WO2009010303A3 (en) 2009-05-07

Family

ID=39929808

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/005919 WO2009010303A2 (en) 2007-07-18 2008-07-18 System for administering active substances to an organism, devices for use in said type of system and method for producing said type of devices

Country Status (1)

Country Link
WO (1) WO2009010303A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008033805A1 (en) * 2008-07-18 2010-01-21 Neue Magnetodyn Gmbh A system for acquiring readings in or on an organism and method for making a component of that system
US8568027B2 (en) 2009-08-26 2013-10-29 Ut-Battelle, Llc Carbon nanotube temperature and pressure sensors
EP2605761A1 (en) * 2010-08-19 2013-06-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Device that is implantable in the temporal bone for delivering a material, and hearing aid provided with such a device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093643A2 (en) * 2003-04-16 2004-11-04 The Children's Hospital Of Philadelphia Magnetically controllable drug and gene delivery stents
WO2005110395A1 (en) * 2004-05-19 2005-11-24 University Of South Carolina System and device for magnetic drug targeting with magnetic drug carrier particles

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093643A2 (en) * 2003-04-16 2004-11-04 The Children's Hospital Of Philadelphia Magnetically controllable drug and gene delivery stents
WO2005110395A1 (en) * 2004-05-19 2005-11-24 University Of South Carolina System and device for magnetic drug targeting with magnetic drug carrier particles

Also Published As

Publication number Publication date
WO2009010303A2 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
Kozielski et al. Nonresonant powering of injectable nanoelectrodes enables wireless deep brain stimulation in freely moving mice
Christiansen et al. Magnetic strategies for nervous system control
Sharma et al. Mathematical modelling for trajectories of magnetic nanoparticles in a blood vessel under magnetic field
US20070282156A1 (en) Apparatus For Generating Electric Current Field In The Human Body And Method For The Use Thereof
Tehrani et al. A novel scheme for nanoparticle steering in blood vessels using a functionalized magnetic field
WO2011076415A3 (en) Valve for a magnetorheological liquid
WO2015142922A8 (en) System with an electromagnetic field generator with coils for treating tumors and a method for treating tissue
EP2062225B8 (en) Method and system for displaying the electric field generated on the brain by transcranial magnetic stimulation
WO2009155700A8 (en) Radiation therapy system
Aviles et al. Implant assisted-magnetic drug targeting: Comparison of in vitro experiments with theory
CN106573069A (en) Methods for killing cancer cells and cellular imaging using magneto-electric nano-particles and external magnetic field
PL2967419T3 (en) A method and system for determiing a corrected value of magnetic resonance relaxometry data of a subject's visceral tissue for extracellular fluid based on a normal iron content for the visceral tissue
Balaev et al. Mechanism of the formation of an uncompensated magnetic moment in bacterial ferrihydrite nanoparticles
Mousavi et al. Effect of non-uniform magnetic field on biomagnetic fluid flow in a 3D channel
WO2016069982A1 (en) Magnetic injection of therapeutic agents by addition of material extrusions with differing magnetization and magnetic permeability
WO2009010303A3 (en) System for administering active substances to an organism, devices for use in said type of system and method for producing said type of devices
Hajiaghajani et al. Adaptable setups for magnetic drug targeting in human muscular arteries: Design and implementation
GB2476757A (en) Magnetic stimulation coils with electrically conducting structures
Wawrzik et al. Magnetic particle imaging: exploring particle mobility
CN104622104A (en) Health mattress with enhancement of local magnetic field
Colbert et al. Static magnetic field therapy: dosimetry considerations
Dadkhah et al. Design and simulation of a 3D actuation system for magnetic nano-particles delivery system
WO2011011488A8 (en) A multicomponent magnetic nanoparticle delivery system for local delivery to heart valve leaflets and other animal tissues
Mukherjee et al. A miniaturized, low-frequency magnetoelectric wireless power transfer system for powering biomedical implants
WO2018200917A1 (en) Detection and modulation of electrical states in living tissues

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08784894

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08784894

Country of ref document: EP

Kind code of ref document: A2